AFP and hepatocellular carcinoma: This group had a higher diagnostic ability than AFP in differentiating HCC from high-risk patients with cirrhosis, identifying HCC patients with false-negative AFP, screening small HCC (s-HCC) patients from high-risk patients, and distinguishing HCC from other cancers [54].